Comparison of Apoptotic Inducing Effect of Zerumbone and Zerumbone-Loaded Nanostructured Lipid Carrier on Human Mammary Adenocarcinoma MDA-MB-231 Cell Line

Figure 6

Cell cycle analysis of MDA-MB-231 cells treated with ((d), (e), (f)) ZER and ((g), (h), (i)) ZER-NLC after 24, 48, and 72 hours. (a), (b), and (c) are untreated cells after 24, 48, and 72 h, respectively.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)